Fortress Biotech, Inc. - FORM 10-K - EX-21.1 - EXHIBIT 21.1 - March 16, 2018

Attached files

file filename
EX-10.39 - EXHIBIT 10.39 - Fortress Biotech, Inc.tv487010_ex10-39.htm
EX-32.2 - EXHIBIT 32.2 - Fortress Biotech, Inc.tv487010_ex32-2.htm
EX-32.1 - EXHIBIT 32.1 - Fortress Biotech, Inc.tv487010_ex32-1.htm
EX-31.2 - EXHIBIT 31.2 - Fortress Biotech, Inc.tv487010_ex31-2.htm
EX-31.1 - EXHIBIT 31.1 - Fortress Biotech, Inc.tv487010_ex31-1.htm
EX-23.2 - EXHIBIT 23.2 - Fortress Biotech, Inc.tv487010_ex23-2.htm
EX-23.1 - EXHIBIT 23.1 - Fortress Biotech, Inc.tv487010_ex23-1.htm
10-K - FORM 10-K - Fortress Biotech, Inc.tv487010_10k.htm

 

EXHIBIT 21.1

 

SUBSIDIARIES OF FORTRESS BIOTECH, INC.

 

Subsidiaries of Fortress Biotech, Inc. at December 31, 2017, with jurisdiction of incorporation or formation:

 

•Aevitas Therapeutics, Inc. (Delaware)
•Avenue Therapeutics, Inc. (Delaware)’
•Caelum Biosciences, Inc. (Delaware), formerly FBIO Acquisition Corp. II
•CB Securities Corporation (Massachusetts)
•Cellvation Inc. (Delaware), formerly FBIO Acquisition Corp. I
•Checkpoint Therapeutics, Inc. (Delaware)
•Cyprium Therapuetics, Inc. (Delaware)
•Coronado SO Co. (Delaware)
•Escala Therapeutics, Inc., formerly Altamira Biosciences, Inc. (Delaware)
•FBIO Acquisition Corp. IV, VI – XIV (Delaware)
•GeneXion Oncology, Inc. (Delaware), formerly FBIO Acquisition Corp. III
•Helocyte, Inc., formerly DiaVax Biosciences, Inc. (Delaware)
•Innmune Limited (United Kingdom)
•Journey Medical Corporation (Delaware)
•Mustang Bio, Inc. (Delaware)
•National Holdings Corporation (Delaware).
•Tamid Bio, Inc. (Delaware), formerly FBIO Acquisition Corp. V

 

 

Fortress Biotech, Inc. Reports